Annual Working Capital
$11.16 M
-$12.89 M-53.60%
31 December 2023
Summary:
Cytosorbents annual working capital is currently $11.16 million, with the most recent change of -$12.89 million (-53.60%) on 31 December 2023. During the last 3 years, it has fallen by -$61.14 million (-84.57%). CTSO annual working capital is now -84.57% below its all-time high of $72.30 million, reached on 31 December 2020.CTSO Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$8.17 M
-$3.45 M-29.71%
30 September 2024
Summary:
Cytosorbents quarterly working capital is currently $8.17 million, with the most recent change of -$3.45 million (-29.71%) on 30 September 2024. Over the past year, it has increased by +$879.00 thousand (+12.06%). CTSO quarterly working capital is now -89.72% below its all-time high of $79.45 million, reached on 30 September 2020.CTSO Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTSO Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -53.6% | +12.1% |
| 3 y3 years | -84.6% | -86.8% |
| 5 y5 years | -47.7% | -37.4% |
CTSO Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -84.6% | at low | -86.8% | +24.3% |
| 5 y | 5 years | -84.6% | +1.8% | -89.7% | +24.3% |
| alltime | all time | -84.6% | +2355.7% | -89.7% | +775.7% |
Cytosorbents Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.17 M(-29.7%) |
| June 2024 | - | $11.62 M(+76.9%) |
| Mar 2024 | - | $6.57 M(-41.1%) |
| Dec 2023 | $11.16 M(-53.6%) | $11.16 M(+53.1%) |
| Sept 2023 | - | $7.29 M(-45.2%) |
| June 2023 | - | $13.29 M(-25.0%) |
| Mar 2023 | - | $17.73 M(-26.3%) |
| Dec 2022 | $24.05 M(-52.5%) | $24.05 M(+8.0%) |
| Sept 2022 | - | $22.26 M(-28.4%) |
| June 2022 | - | $31.09 M(-24.5%) |
| Mar 2022 | - | $41.18 M(-18.6%) |
| Dec 2021 | $50.61 M(-30.0%) | $50.61 M(-18.0%) |
| Sept 2021 | - | $61.68 M(-7.0%) |
| June 2021 | - | $66.29 M(-5.1%) |
| Mar 2021 | - | $69.88 M(-3.4%) |
| Dec 2020 | $72.30 M(+559.4%) | $72.30 M(-9.0%) |
| Sept 2020 | - | $79.45 M(+202.3%) |
| June 2020 | - | $26.28 M(+0.8%) |
| Mar 2020 | - | $26.07 M(+137.7%) |
| Dec 2019 | $10.97 M(-48.6%) | $10.97 M(-16.0%) |
| Sept 2019 | - | $13.05 M(-14.7%) |
| June 2019 | - | $15.30 M(-15.6%) |
| Mar 2019 | - | $18.12 M(-15.1%) |
| Dec 2018 | $21.35 M(+65.6%) | $21.35 M(-16.9%) |
| Sept 2018 | - | $25.69 M(-5.9%) |
| June 2018 | - | $27.29 M(+32.9%) |
| Mar 2018 | - | $20.53 M(+59.3%) |
| Dec 2017 | $12.89 M(+263.1%) | $12.89 M(-5.3%) |
| Sept 2017 | - | $13.61 M(+0.7%) |
| June 2017 | - | $13.51 M(>+9900.0%) |
| Mar 2017 | - | $98.10 K(-97.2%) |
| Dec 2016 | $3.55 M(-47.9%) | $3.55 M(-12.4%) |
| Sept 2016 | - | $4.05 M(-43.2%) |
| June 2016 | - | $7.14 M(+49.0%) |
| Mar 2016 | - | $4.79 M(-29.7%) |
| Dec 2015 | $6.82 M | $6.82 M(-16.3%) |
| Sept 2015 | - | $8.14 M(-22.5%) |
| June 2015 | - | $10.51 M(+21.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $8.68 M(+180.0%) |
| Dec 2014 | $3.10 M(+635.0%) | $3.10 M(-58.1%) |
| Sept 2014 | - | $7.41 M(-5.7%) |
| June 2014 | - | $7.85 M(-7.9%) |
| Mar 2014 | - | $8.53 M(+1921.1%) |
| Dec 2013 | $422.00 K(-51.1%) | $422.00 K(-27.0%) |
| Sept 2013 | - | $578.30 K(+19.8%) |
| June 2013 | - | $482.90 K(-57.5%) |
| Mar 2013 | - | $1.14 M(+31.6%) |
| Dec 2012 | $862.90 K(+409.1%) | $862.90 K(+10.7%) |
| Sept 2012 | - | $779.50 K(+380.3%) |
| June 2012 | - | $162.30 K(+47.9%) |
| Mar 2012 | - | $109.70 K(-35.3%) |
| Dec 2011 | $169.50 K(-6.4%) | $169.50 K(-81.7%) |
| Sept 2011 | - | $927.40 K(-54.4%) |
| June 2011 | - | $2.03 M(+63.9%) |
| Mar 2011 | - | $1.24 M(+585.0%) |
| Dec 2010 | $181.10 K(-81.8%) | $181.10 K(-115.0%) |
| Sept 2010 | - | -$1.21 M(+120.0%) |
| June 2010 | - | -$549.50 K(-660.7%) |
| Mar 2010 | - | $98.00 K(-90.1%) |
| Dec 2009 | $993.90 K(-52.4%) | $994.00 K(+1062.6%) |
| Sept 2009 | - | $85.50 K(-85.0%) |
| June 2009 | - | $570.20 K(-57.8%) |
| Mar 2009 | - | $1.35 M(-35.3%) |
| Dec 2008 | $2.09 M(-522.2%) | $2.09 M(-19.6%) |
| Sept 2008 | - | $2.60 M(+0.2%) |
| June 2008 | - | $2.59 M(-386.7%) |
| Mar 2008 | - | -$903.50 K(+82.7%) |
| Dec 2007 | -$494.60 K(-127.2%) | -$494.60 K(-2942.5%) |
| Sept 2007 | - | $17.40 K(+314.3%) |
| June 2007 | - | $4200.00(-99.5%) |
| Mar 2007 | - | $788.30 K(-56.6%) |
| Dec 2006 | $1.82 M | $1.82 M(+48.7%) |
| Sept 2006 | - | $1.22 M(-4.8%) |
| June 2006 | - | $1.28 M(-1431.3%) |
| Feb 2006 | - | -$96.40 K(+11.4%) |
| Nov 2005 | - | -$86.50 K(+12.5%) |
| Aug 2005 | - | -$76.90 K |
FAQ
- What is Cytosorbents annual working capital?
- What is the all time high annual working capital for Cytosorbents?
- What is Cytosorbents annual working capital year-on-year change?
- What is Cytosorbents quarterly working capital?
- What is the all time high quarterly working capital for Cytosorbents?
- What is Cytosorbents quarterly working capital year-on-year change?
What is Cytosorbents annual working capital?
The current annual working capital of CTSO is $11.16 M
What is the all time high annual working capital for Cytosorbents?
Cytosorbents all-time high annual working capital is $72.30 M
What is Cytosorbents annual working capital year-on-year change?
Over the past year, CTSO annual working capital has changed by -$12.89 M (-53.60%)
What is Cytosorbents quarterly working capital?
The current quarterly working capital of CTSO is $8.17 M
What is the all time high quarterly working capital for Cytosorbents?
Cytosorbents all-time high quarterly working capital is $79.45 M
What is Cytosorbents quarterly working capital year-on-year change?
Over the past year, CTSO quarterly working capital has changed by +$879.00 K (+12.06%)